Precision Medicine Targeting FGFR2 Genomic Alterations in Advanced Cholangiocarcinoma: Current State and Future Perspectives

Although a relatively uncommon tumor, cholangiocarcinoma is on the rise globally. Of note, most patients are diagnosed with metastatic disease, and the prognosis is poor with cytotoxic chemotherapy. Strategies targeting specific genomic alterations have demonstrated promising activity in recent year...

Descripción completa

Detalles Bibliográficos
Autores principales: Zugman, Miguel, Botrus, Gehan, Pestana, Roberto Carmagnani, Uson Junior, Pedro Luiz Serrano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013963/
https://www.ncbi.nlm.nih.gov/pubmed/35444941
http://dx.doi.org/10.3389/fonc.2022.860453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013963/
https://www.ncbi.nlm.nih.gov/pubmed/35444941
http://dx.doi.org/10.3389/fonc.2022.860453

Ejemplares similares